Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| basal cell | 10 studies | 25% ± 5% | |
| macrophage | 6 studies | 23% ± 7% | |
| epithelial cell | 6 studies | 25% ± 10% | |
| Mueller cell | 4 studies | 27% ± 6% | |
| alveolar macrophage | 3 studies | 16% ± 1% | |
| type I pneumocyte | 3 studies | 24% ± 8% |
Insufficient scRNA-seq data for expression of AVPI1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| skin | 100% | 4711.34 | 1809 / 1809 | 99% | 120.96 | 469 / 472 |
| ovary | 100% | 5522.54 | 180 / 180 | 98% | 29.31 | 422 / 430 |
| adrenal gland | 100% | 2530.53 | 258 / 258 | 98% | 47.58 | 225 / 230 |
| bladder | 100% | 1828.24 | 21 / 21 | 97% | 64.42 | 491 / 504 |
| lung | 98% | 1623.64 | 568 / 578 | 99% | 64.57 | 1141 / 1155 |
| esophagus | 97% | 2486.38 | 1400 / 1445 | 100% | 71.84 | 183 / 183 |
| liver | 97% | 1619.60 | 219 / 226 | 100% | 45.87 | 404 / 406 |
| intestine | 97% | 1266.38 | 937 / 966 | 99% | 66.59 | 522 / 527 |
| prostate | 100% | 1922.06 | 244 / 245 | 93% | 28.39 | 469 / 502 |
| uterus | 94% | 1051.43 | 159 / 170 | 98% | 103.59 | 451 / 459 |
| stomach | 93% | 1742.62 | 333 / 359 | 99% | 65.19 | 282 / 286 |
| breast | 98% | 1496.23 | 449 / 459 | 93% | 25.30 | 1040 / 1118 |
| brain | 89% | 990.12 | 2342 / 2642 | 94% | 24.00 | 661 / 705 |
| thymus | 78% | 603.39 | 508 / 653 | 95% | 39.45 | 575 / 605 |
| kidney | 71% | 633.90 | 63 / 89 | 87% | 20.20 | 783 / 901 |
| pancreas | 20% | 111.43 | 64 / 328 | 99% | 54.76 | 176 / 178 |
| eye | 0% | 0 | 0 / 0 | 100% | 80.67 | 80 / 80 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 62.90 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 47.93 | 1 / 1 |
| blood vessel | 100% | 2437.19 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| adipose | 99% | 2024.17 | 1195 / 1204 | 0% | 0 | 0 / 0 |
| spleen | 85% | 1411.83 | 206 / 241 | 0% | 0 | 0 / 0 |
| heart | 73% | 725.85 | 629 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 41% | 5.99 | 12 / 29 |
| muscle | 37% | 368.78 | 294 / 803 | 0% | 0 | 0 / 0 |
| peripheral blood | 25% | 222.54 | 232 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0043410 | Biological process | positive regulation of MAPK cascade |
| GO_0005515 | Molecular function | protein binding |
| Gene name | AVPI1 |
| Protein name | Arginine vasopressin-induced protein 1 (AVP-induced protein 1) |
| Synonyms | NPD013 PP5395 |
| Description | FUNCTION: May be involved in MAP kinase activation, epithelial sodium channel (ENaC) down-regulation and cell cycling. . |
| Accessions | ENST00000370626.4 Q5T686 |
